357 related articles for article (PubMed ID: 15052306)
1. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols.
Kuo If; Chen J; Chang TK
Can J Physiol Pharmacol; 2004 Jan; 82(1):57-64. PubMed ID: 15052306
[TBL] [Abstract][Full Text] [Related]
2. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes.
Chang TK; Chen J; Teng XW
Drug Metab Dispos; 2006 Feb; 34(2):234-42. PubMed ID: 16258077
[TBL] [Abstract][Full Text] [Related]
3. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
Chang TK; Chen J; Yeung EY
Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.
Lau AJ; Chang TK
Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249
[TBL] [Abstract][Full Text] [Related]
5. Bilobalide in Ginkgo biloba extract is a major substance inducing hepatic CYPs.
Umegaki K; Taki Y; Endoh K; Taku K; Tanabe H; Shinozuka K; Sugiyama T
J Pharm Pharmacol; 2007 Jun; 59(6):871-7. PubMed ID: 17637180
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of extract of leaves of ginkgo (Ginkgo biloba) and its component bilobalide on azoxymethane-induced colonic aberrant crypt foci in rats.
Suzuki R; Kohno H; Sugie S; Sasaki K; Yoshimura T; Wada K; Tanaka T
Cancer Lett; 2004 Jul; 210(2):159-69. PubMed ID: 15183531
[TBL] [Abstract][Full Text] [Related]
7. Modulation of CYP1A1 activity by a Ginkgo biloba extract in the human intestinal Caco-2 cells.
Ribonnet L; Callebaut A; Nobels I; Scippo ML; Schneider YJ; De Saeger S; Pussemier L; Larondelle Y
Toxicol Lett; 2011 May; 202(3):193-202. PubMed ID: 21329749
[TBL] [Abstract][Full Text] [Related]
8. Age-related changes in the vasodilating actions of Ginkgo biloba extract and its main constituent, bilobalide, in rat aorta.
Nishida S; Satoh H
Clin Chim Acta; 2005 Apr; 354(1-2):141-6. PubMed ID: 15748610
[TBL] [Abstract][Full Text] [Related]
9. Suppression of pacemaker activity by Ginkgo biloba extract and its main constituent, bilobalide in rat sino-atrial nodal cells.
Satoh H
Life Sci; 2005 Nov; 78(1):67-73. PubMed ID: 16182317
[TBL] [Abstract][Full Text] [Related]
10. Induction of cytochrome P450s by terpene trilactones and flavonoids of the Ginkgo biloba extract EGb 761 in rats.
Deng Y; Bi HC; Zhao LZ; He F; Liu YQ; Yu JJ; Ou ZM; Ding L; Chen X; Huang ZY; Huang M; Zhou SF
Xenobiotica; 2008 May; 38(5):465-81. PubMed ID: 18421621
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a gas chromatographic-mass spectrometric method for simultaneous identification and quantification of marker compounds including bilobalide, ginkgolides and flavonoids in Ginkgo biloba L. extract and pharmaceutical preparations.
Deng F; Zito SW
J Chromatogr A; 2003 Jan; 986(1):121-7. PubMed ID: 12585329
[TBL] [Abstract][Full Text] [Related]
12. Selective responses of three Ginkgo biloba leaf-derived constituents on human intestinal bacteria.
Lee HS; Kim MJ
J Agric Food Chem; 2002 Mar; 50(7):1840-4. PubMed ID: 11902921
[TBL] [Abstract][Full Text] [Related]
13. Modulation of CYP1B1 and CYP1A1 gene expression and activation of aryl hydrocarbon receptor by Ginkgo biloba extract in MCF-10A human mammary epithelial cells.
Rajaraman G; Yang G; Chen J; Chang TK
Can J Physiol Pharmacol; 2009 Sep; 87(9):674-83. PubMed ID: 19794518
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.
Ahlemeyer B; Krieglstein J
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S8-14. PubMed ID: 13130383
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids.
Mohamed MF; Frye RF
Drug Metab Dispos; 2010 Feb; 38(2):270-5. PubMed ID: 19889883
[TBL] [Abstract][Full Text] [Related]
16. Effect of Ginkgo biloba extract on oxidative metabolism of valproic acid in hepatic microsomes from donors with the CYP2C9*1/*1 genotype.
Numa AM; Abbott FS; Chang TK
Can J Physiol Pharmacol; 2007 Sep; 85(9):848-55. PubMed ID: 18066130
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human cytochromes P450 by components of Ginkgo biloba.
von Moltke LL; Weemhoff JL; Bedir E; Khan IA; Harmatz JS; Goldman P; Greenblatt DJ
J Pharm Pharmacol; 2004 Aug; 56(8):1039-44. PubMed ID: 15285849
[TBL] [Abstract][Full Text] [Related]
18. Bilobalide, a constituent of Ginkgo biloba L., potentiates drug-metabolizing enzyme activities in mice: possible mechanism for anticonvulsant activity against 4-O-methylpyridoxine-induced convulsions.
Sasaki K; Wada K; Hatta S; Ohshika H; Haga M
Res Commun Mol Pathol Pharmacol; 1997 Apr; 96(1):45-56. PubMed ID: 9178367
[TBL] [Abstract][Full Text] [Related]
19. Isolation of ginkgolides A, B, C, J and bilobalide from G. biloba extracts.
Jaracz S; Malik S; Nakanishi K
Phytochemistry; 2004 Nov; 65(21):2897-902. PubMed ID: 15501258
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic herb-disease-drug interactions: Effect of ginkgo biloba extract on the pharmacokinetics of pitavastatin, a substrate of Oatp1b2, in rats with non-alcoholic fatty liver disease.
Li Z; Tian S; Wu Z; Xu X; Lei L; Li Y; Wang B; Huang Y
J Ethnopharmacol; 2021 Nov; 280():114469. PubMed ID: 34329714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
